How Has the Artificial Tears Market Evolved Historically and What is its Current Size?
The artificial tears market has seen considerable growth due to a variety of factors.
• Over the past few years, the market size of artificial tears has seen significant growth. The market valuation is expected to increase from $3.55 billion in 2024 to $3.78 billion in 2025, recording a compound annual growth rate (CAGR) of 6.5%.
Factors such as an aging population, extended screen time, healthcare spending, transition from prescription to OTC, and regulatory modifications have contributed to the growth during the historic period.
What Does Future Hold for The Artificial Tears Market By 2029?
The artificial tears market is expected to maintain its strong growth trajectory in upcoming years.
• The market for artificial tears is projected to demonstrate robust expansion in the coming years, swelling to a valuation of $4.86 billion by 2029, representing a compound annual growth rate (CAGR) of 6.5%.
This upsurge during the projected timeframe can be associated with factors such as the rising incidence of dry eye syndrome, increased use of contact lenses, global urbanization, escalating pollution, and the expansion of e-commerce. Foreseen trends for the forecast period encompass technological evolution, incorporation of AI and technology, alliances with healthcare professionals, the introduction of natural elements, improvements in product formulation, sophisticated drug delivery systems, and environmentally friendly products.
What Are The Primary Growth Drivers In The Artificial Tears Market?
The growth of the artificial tear market is slated to be driven by the increasing cases of dry eye disease. This medical condition, wherein the eyes do not generate adequate tears, or the quality of the produced tears is insufficient, often causes discomfort and irritation. By supplementing natural tear production, artificial tears provide both relief and lubrication for dry eyes. As per a survey conducted by the Australia-based Macquarie University in March 2022, it was found that amongst respondents aged 50 or more, 13% (15 out of 120) exhibited clinical symptoms of dry eye disease (DED) with 8.2% being mild, 2.5% moderate, and 1.6% categorized as severe. Moreover, Eyes On Eyecare, a US digital news provider focused on ophthalmology, noted in March 2022 that the uptake of prescribed and in-office treatments for dry eye disease witnessed an increase from 5.8% in 2021 to 7.56% in 2022. Prescription treatments such as topical steroids also saw a notable increase from 0.9% to 9.1% during the same timeframe. Consequently, the increasing instances of dry eye disease are fueling the growth of the artificial tear market.
What Is The Segmentation Of The Global Artificial Tears Market?
The artificial tears market covered in this report is segmented –
1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears
2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray
3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications
4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores
Subsegments:
1) By Glycerin Tears: Preserved Glycerin Tears, Preservative-Free Glycerin Tears
2) By Cellulose Tears: Hydroxypropyl Methylcellulose (HPMC) Tears, Carboxymethylcellulose (CMC) Tears
3) By Oil-Based Emulsion Tears: Mineral Oil-based Tears, Castor Oil-based Tears
4) By Polyethylene Glycol-based Tears: PEG 400 Tears, PEG 3350 Tears
5) By Sodium Hyaluronate Based Artificial Tears: Low Molecular Weight Sodium Hyaluronate Tears, High Molecular Weight Sodium Hyaluronate Tears
6) By Propylene Glycol-based Tears: Preserved Propylene Glycol Tears, Preservative-Free Propylene Glycol Tears
Pre-Book The Artificial Tears Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Artificial Tears Market?
Leaders in the artificial tears market are engineering products with modern technologies like the patented pureflow method to improve product safety and user-friendliness. This patented pureflow technology is a unique delivery system using a unidirectional valve to guarantee the sterile distribution of preservative-free eye drops, averting contamination and preserving product quality. For example, in January 2022, Alcon Inc., a medical device and pharmaceutical company based in Switzerland, introduced Systane Complete Preservative-Free Lubricant Eye Drops. These improved artificial tears are specifically concocted to alleviate all major dry eye symptoms including evaporative dry eye and aqueous tear deficiency. As a preservative-free preparation, they give up to eight hours of prolonged relief by moisturizing and safeguarding every layer of the tear film. The drops use nano-drop technology to supply instant hydration to the eye surface, hindering tear evaporation and providing quick, effective relief. Contained in a handy multi-dose bottle with PureFlow technology, the design assures safety by thwarting contamination, making it a superior option for regular users and those with sensitive eyes.
Who Are the Key Players In The Artificial Tears Market?
Major companies operating in the artificial tears market report are:
• Pfizer Inc.
• Johnson & Johnson
• AbbVie Inc.
• Novartis AG
• Abbott Laboratories
• Otsuka Pharmaceutical Co. Ltd.
• Alcon
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Dr Reddy's Laboratories
• Santen Pharmaceutical Co. Ltd.
• Lupin Limited
• Rohto Pharmaceutical Co. Ltd.
• Prestige Consumer Healthcare Inc.
• Thea Pharma Inc.
• OPTIMA pharma GmbH
• Sentiss Pharma Pvt. Ltd.
• VISUfarma B.V.
• OASIS Medical Inc.
• Hilco Vision
• Similasan Corporation
• Eyevance Pharmaceuticals LLC
• Nicox S.A.
• I-MED Pharma Inc.
• Velocity Pharma LLC
What Are The Regional Insights Into The Artificial Tears Market?
North America was the largest region in the artificial tears market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
